CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Highlighted in Comprehensive Research Report

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, was recently covered in a research report by Eight Capital. Per the report, Eight Capital issued a ‘Buy’ rating and a target price of $4.50 for WLLW, determined in part by Willow’s chosen method of cannabinoid production, biosynthesis, which holds the potential to disrupt the industry. The report also detailed upcoming catalysts for the company, including the potential formation of partnerships and agreements; quantitative milestones demonstrating increased throughput of the company’s proprietary yeast strains; planned uplisting to the Toronto Stock Exchange; and securing intellectual property (“IP”) assets. For detailed information regarding the research report, contact Info@WillowBio.com.

For more information, visit www.WillowBio.com.

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Stock Option Grant and Unit Issuance

Willow Biosciences Inc. (CSE: WLLW) on Tuesday announced that it has granted an aggregate of 1,118,000 stock options for certain employees to purchase common shares of Willow pursuant to the terms and conditions of its stock option plan. According to the update, the options expire five years from the grant date, are exercisable at a price of $0.60 per common share, and vest as to one third on the grant date and on each of the first and second anniversaries of the grant date. Willow has additionally issued 21,057 units of the company in connection with its previous April 2019 private placement. The units were issued as of the date hereof, each at an issuance price of $0.875 and consisting of one common share and one performance-based common share purchase warrant. The units were issued at the same price (on a post-consolidation basis) and the warrants have the same terms as those issued under the company’s April 2019 private placement.

To view the full press release, visit http://cnw.fm/cyrM7

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Mississippians Likely to Vote on Medical Cannabis After Ballot Measure Signatures Are Submitted

Voters in Mississippi are likely to be given a chance to cast their vote to decide whether medical marijuana should be legalized in the state after a group of activists submitted a list containing more than the minimum number of voter signatures required to put the matter on the 2020 ballot.

Though the signatures that were submitted on Wednesday this week still have to be verified by the Mississippi Secretary of State, Mississippians for Compassionate Care (MCC), the group behind the campaign to put the matter before voters, are confident that all is set after they submitted lists containing in excess of…

Read More >>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Engages The Howard Group; Presenting at the 8th Annual Gateway Conference

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, on Tuesday announced its engagement of The Howard Group as its capital markets communications advisor. The engagement is for twelve months at a fee of $9,000 per month, effective August 15, 2019, and is renewable after six months. In this role, The Howard Group will assist Willow with traditional and online initiatives that target the investment community in addition to institutional and retail investing groups. The Howard Group will also provide ongoing commentary on the company’s activities through its blog (http://cnw.fm/7VSvJ). Additionally, Willow announced that it will be presenting at the 8th Annual Gateway Conference taking place at the Four Seasons Hotel in San Francisco at 1:00 PM PT on Thursday, September 5th. Willow management will also be holding one-on-one meetings throughout the conference.

To view the full press release, visit http://cnw.fm/I7CJh

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Releases Q2 2019 Results and Provides Operational Update

Willow Biosciences (CSE: WLLW) today released its financial results for the three and six months ended June 30, 2019 and provided an operational update. Among highlights for the quarter, the company reported that it has: expanded its operations to include three facilities located in Calgary, Alberta, Mountain View, California and Burnaby, British Columbia; made key appointments to its management team and board of directors; entered an exclusive Joint Development Agreement (“JDA”) with Noramco; and completed a reverse takeover and raised gross proceeds of approximately $37.0 million. “Over the past few months, we have made impressive progress in advancing our business on several important fronts,” Willow President and Chief Executive Officer Trevor Peters said in the news release. “We have assembled a team of proven business executives and world-renowned scientists to lead the development of our high-quality consumer, wellness, and pharmaceutical ingredient manufacturing programs. The development of our yeast-based cannabinoid production platform is progressing well and we expect to initiate the scaling up of our process in the first half of 2020. In addition to advancing our development operations, we are focused on positioning Willow for successful future commercialization through our recently signed strategic partnership with Noramco, Inc. (Noramco), one of the world’s leading pharmaceutical cannabinoid ingredient producers.”

To view the full press release, visit http://cnw.fm/Nh99B

About Willow Biosciences Inc.

Headquartered in Calgary, Canada, Willow and its team of scientists are leaders in the field of biosynthetic production of high-value, plant-derived compounds. Willow has applied its integrated suite of technologies to develop manufacturing processes for numerous active pharmaceutical ingredients with various therapeutic benefits, including cancer treatment, pain management and CNS disorders. In the cannabinoid field, Willow owns proprietary, yeast-based lab strains that produce CBD, tetrahydrocannabinol (THC) and cannabigerol (CBG), as well as certain minor and novel cannabinoids. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Federally Funded Journal Reveals How Prohibition is Endangering Marijuana Consumers

It is ironical that federal dollars were used to publish a journal report which blames the federal prohibition of marijuana for putting cannabis consumers at risk since there is no federal guidance on the safety standards that the industry should adhere to.

Environmental Health Perspectives, an open access journal whose work is supported by funding from the National Institutes of Health, published this damning report in its..

Read More >>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why You Should Inform Your Anesthesiologist About Your Cannabis Use

Doctors in Colorado are urging their patients to disclose their cannabis use habits if the patients are due to undergo a surgical procedure regardless of whether that surgery is routine or major surgery.

This call comes after a small study was done on how the medical community was using one common anesthetic drug, propofol, which is used to sedate patients before surgery. The researchers found that on average, the people who used marijuana required approximately thrice the amount of sedation that non-cannabis users required.

These results made the researchers to wonder what additional risks, such as breathing problems, marijuana users may face when they undergo surgery using such high amounts of anesthetics.

In partial response to such concerns, the American Association of Nurse Anesthetists updated the guidelines its members use during their work. The amended guidelines now require anesthetic nurses to take additional steps to keep the airways of marijuana users clear while the patients undergo surgery. Another provision also advises the nurses to refrain from using any anesthetic drugs (sedatives) that could potentially affect the heart rate of marijuana users.

The doctors in Colorado explain that they picked interest in the patients’ use of marijuana because the drug can affect how much sedation should be administered prior to a surgical procedure.

Luckily for the medical professionals in Colorado, marijuana has been legal for years, so patients are unlikely to be guarded about revealing their cannabis use habits. This is because the stigma directed at marijuana users has been knocked back to a great extent.

This open discussion with doctors is timely, because the National Survey on Drug Use and Health done in 2017 indicated that the number of people in Colorado who reported that they had used marijuana at least once within the past 30 days increased to 17 percent from 8 percent in 2006 when a similar survey was done. For comparison, the average past 30-day marijuana use in the country is 9 percent.

The larger proportion of people using marijuana in the state means that more people could be exposed to risks during and after surgery if the patients aren’t forthcoming to their doctors so that appropriate precautions are taken.

While more research may still be needed to ascertain what specific effects marijuana use brings to patients besides requiring larger doses of sedatives, it is in your best interest to let your doctor know even if you live in an area where marijuana is still illegal. The risks of keeping quiet about your marijuana use as you go in for surgery outweigh those of full disclosure.

For now, everyone, including marijuana industry participants like Willow Biosciences Corp. (CSE: WLLW) and Youngevity International Inc. (NASDAQ: YGYI), who minds about people’s health would like the scientific community to speed up their inquiry into what the medical community needs to do to keep marijuana users safe before, during and after undergoing surgery. Otherwise, scaremongers may use the gap to spread unfounded rumors about cannabis use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Utah Medical Cannabis Program Stays on Course as State Dismisses Protests

Utah selected eight firms towards the end of last month to undergo background checks prior to being granted licenses to grow medical marijuana as the state moves to implement a voter decision during the 2018 midterms. However, six companies that weren’t successful during the application process protested to the state’s Division of Purchasing. The division has responded by dismissing those protests, thereby paving the way for the state to stay on course in its bid to implement the medical marijuana program.

The companies that protested to the Division of Purchasing are North Star Holdings, Pure UT, Wild West Holding, Tintic United Bioscience, JLPR, and Total Health Sciences. These companies were unhappy that Utah had only selected eight companies yet the law provides for a maximum of ten growers.

However, the Division of Purchasing argued that it took the decision to select only eight cultivators in order to avert the possibility of over-supply in the medical cannabis market. They added that the law allows the division to select any number of cultivators as long as the legal cap isn’t exceeded.

Chris Hughes, the director of Utah’s Division of Purchasing, announced on Wednesday that the companies whose appeals had been dismissed could escalate their protest to the Utah Procurement Policy Board and even go to court if they weren’t satisfied with the decisions made.

Meanwhile, several county attorneys are putting pressure on Utah to abandon its plans of having a state-run medical cannabis dispensary system. They say that the current design of the system will put the employees of the state at the risk of prosecution under the existing drug laws of the federal government.

Troy Rawlings (DA Davis County) and Sim Gill (DA Salt Lake County) insist that using the local dispensaries as points where medical marijuana can be picked up would, in effect, turn the county’s medical department workers into drug traffickers in the eyes of the federal government.

Under Utah’s medical marijuana law, seven private medical marijuana pharmacies will be licensed while a “central fill pharmacy” will be run by the state to supply the private pharmacies with the products they put on their shelves. This “fill pharmacy” function will be implemented through the 13 local health departments.

State officials acknowledge the concerns of the DAs and a meeting has been planned for later this month in order to discuss any alternatives that could sidestep the risks that the district attorneys point out.

Industry analysts believe that the whole industry, including players like Willow Biosciences Inc. (CSE: WLLW) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), will be hoping that the program in Utah doesn’t run into any hurdles that take implementation beyond the planned 2020 launch date.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants

The registered medical marijuana caregivers in Michigan are authorized to grow more than a million cannabis plants, according to state statistics. This information is crucial as the state transitions from a purely medical cannabis program to one that embraces the recreational use of the drug by adults.

Even if the state accelerates the process by which new commercial growers are licensed, it is unlikely that any of those licensees will have harvested, processed and distributed their marijuana crop at the time recreational sales are launched.

In August 2017, Andrew Brisbo, the Director of the Bureau of Medical Marijuana Regulation stated that approximately 43,000 patients had nominated a caregiver to grow a maximum of 12 cannabis plants for the medical use of the patient.

That statistic means that approximately 1.14 million marijuana plants are under the direct control of the registered caregivers in the state.

Currently, the number of caregivers on the medical marijuana program has risen to an estimated 47,000. This could mean that nearly 1.5 million cannabis plants are grown by these caregivers.

To put this figure in context, the 78 commercial cultivators with state-issued licenses have a 108,000 plant cultivation limit.

All the existing large scale growers and the caregivers currently supply the medical marijuana market whose current patient population stands at 300,000 (Michigan has the second strongest medical marijuana market in the country).

If recreational users come on board, the number of medical marijuana patients will be dwarfed by the number of adults who use cannabis recreationally. Statistics suggest that at least 1.54 million Michigan adults have used recreational marijuana at some point in their lives, so once recreational sales begin, the number of recreational users is likely to be five times that of medical marijuana users.

This means that Michigan could face the same supply shortages that have been witnessed in the states that transition from just medical marijuana markets to recreational cannabis as well. Such supply shortages normally trigger a frenzied expansion of cultivation capacity, which in turn causes a glut once all that extra marijuana finally enters the market.

To prevent the nosedive in prices which results from the glut, Michigan would be well advised to incorporate the caregiver-grown marijuana in the recreational market as well so that the recreational market is kept stable during its first months. This shouldn’t present any quality issues since the caregivers have been supplying the medical cannabis market of the state for years.

Analysts hope that the cannabis industry’s major players in Michigan and elsewhere, such as Youngevity International Inc. (NASDAQ: YGYI) and Willow Biosciences Corp. (CSE: WLLW), will welcome the caregivers whose role provides all-round benefits to all concerned.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Witnesses and Lawmakers Share Views on Federal Marijuana Policy Reform Strategy

Last week, the Crime, Terrorism and Homeland Security sub-committee of the powerful House Judiciary Committee held a landmark session in which they listened to testimony from a variety of experts on how marijuana prohibition could be brought to an end federally.

This hearing was largely focused on evidence, unlike previous Congressional discussions on the matter that largely seemed to be driven by scaremongering. However, there were some disagreements regarding the strategy that should be used to legislate marijuana policy reforms.

For example, Rep. Tom McClintock (R-CA) argued that the Democrats were wrongly framing the issue along racial lines and this would divide the country. The Chairperson of the House Judiciary Committee, Jerrod Nadler, responded by saying that marijuana laws had been designed and implemented in a racially disparate manner, so the solution should also emerge after considering the racial factors involved.

Nadler added that in his own opinion, it is ill-advised to use marijuana, but that doesn’t mean the drug should be criminalized. Instead, adults should be left to make informed decisions on the substance as is the case with other substances like alcohol and cigarettes.

While testifying before the subcommittee, Malik Burnett, a physician at the Johns Hopkins Bloomberg School of Public Health said that it was wrong to have two widely different situations on the subject of marijuana. He explained that the U.S. can be divided into two, with one half made up of whites who are minting billions from state-legal marijuana while the other half of the U.S. made up of poor people, especially blacks, are arrested in their thousands for the same marijuana that whites are getting rich from.

Marilyn Mosby, the State Attorney for Baltimore also told the subcommittee that the current lopsided enforcement of marijuana laws not only worsens the existing inequalities in the U.S. justice system but also alienates the community from law enforcement agencies. No public safety benefit accrues from the enforcement of marijuana prohibition, she added. She concluded by saying that full legalization is the way to go since decriminalization of marijuana isn’t enough. Mosby’s office is noted for announcing earlier this year that they would no longer prosecute marijuana possession cases.

Davis Nathan, the president of Doctors for Cannabis Regulation (a pro-marijuana legalization group of physicians) testified that the prohibition of marijuana has done more harm than any good that was anticipated. He also said that the drug should never have been criminalized since it is less harmful than tobacco and alcohol.

There was a heated discussion regarding the way in which cannabis reform should be made to happen after Neal Levine, the CEO of Cannabis Trade Federation) suggested that the process should be incremental, starting with the passing of the STATES Act currently before lawmakers.

For example, Rep. Steve Cohen (D-TN) wondered why full legalization shouldn’t be done in one fell swoop since prohibition had lingered for far too long. Other lawmakers disagreed and preferred the cautious approach of incremental policy adjustments in order to avoid passing bills that ultimately fail once they reach the Republican-controlled Senate.

Industry pundits strongly believe that the cannabis industry, including players like Willow Biosciences Inc. (CSE: WLLW) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), is hoping that concrete action follows this hearing on the modalities of ending marijuana prohibition.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com